Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa.
about
Disparities in the Magnitude of Human Immunodeficiency Virus-related Opportunistic Infections Between High and Low/Middle-income Countries: Is Highly Active Antiretroviral Therapy Changing the Trend?Incidence of HIV-associated tuberculosis among individuals taking combination antiretroviral therapy: a systematic review and meta-analysisFactors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014-July 2015.Unsuccessful TB treatment outcomes with a focus on HIV co-infected cases: a cross-sectional retrospective record review in a high-burdened province of South Africa.Six-month mortality among HIV-infected adults presenting for antiretroviral therapy with unexplained weight loss, chronic fever or chronic diarrhea in Malawi.Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden countryPrevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.Exposing misclassified HIV/AIDS deaths in South Africa.Determinant factors associated with occurrence of tuberculosis among adult people living with HIV after antiretroviral treatment initiation in Addis Ababa, Ethiopia: a case control studyMortality associated with tuberculosis/HIV co-infection among patients on TB treatment in the Limpopo province, South Africa.The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort studyImpact of previous ART and of ART initiation on outcome of HIV-associated tuberculosis.Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria.Factors Associated with Prevalent Tuberculosis Among Patients Receiving Highly Active Antiretroviral Therapy in a Nigerian Tertiary Hospital.Adherence to antiretrovirals in people coinfected with the human immunodeficiency virus and tuberculosisTemporal association between incident tuberculosis and poor virological outcomes in a South African antiretroviral treatment serviceReducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.Performance of symptom-based tuberculosis screening among people living with HIV: not as great as hopedClinical Outcomes of Tenofovir Versus Zidovudine-based Regimens Among People Living with HIV/AIDS: a Two Years Retrospective Cohort Study.Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.Prognostic indicators in the World Health Organization's algorithm for seriously ill HIV-infected inpatients with suspected tuberculosis.Predictors of mortality in adults on treatment for human immunodeficiency virus-associated tuberculosis in Botswana: A retrospective cohort study.
P2860
Q26752860-5BC23866-7CB2-42AC-8C5D-EDE57BC3796FQ27012753-7C392E60-87D8-479E-9588-A31749DCEDBFQ33634625-3A0BF636-5F6B-4D93-961A-CD16D29A7D71Q33892396-103E1C4A-C7FA-4D7C-BCCF-9171EEAE9D18Q34489764-AAE32817-797C-4874-9617-1A3481361080Q34575195-D1918E42-5A82-4A9A-8C60-97E96F8F7DBBQ34589601-9958C7AD-B303-4D3E-AE43-57D8554660BCQ34734661-B18AF33B-DA31-4111-98E7-2C90369972D3Q34769326-BFEBBB07-F926-4C9A-A526-E76A268E27ACQ35207150-02429F3A-AC36-4815-BF23-FAC6487AA993Q35544835-23DD30DD-8BF7-4546-8DE9-677F96F3B4C7Q35867166-2D4960CE-F2D6-490B-B7A4-3D73F1186B85Q36302953-4F98A259-8645-4BC2-86A9-BB0BC6F6BF11Q36899433-DB9FCE5C-C2B9-4059-A27C-650834BD462BQ36927252-E2A3CBE7-EC3C-432C-BE8A-96BD9A419263Q37284765-04833C50-0CB6-42AF-BA20-4F3F0C098E92Q37285167-74E8A6F4-FF07-4768-B15F-112CD11B73CEQ37424113-5D95C8E1-8992-4073-87BB-DF8F7B98C663Q37635145-93F122B9-5FE1-49B7-86D2-A19FE48C4271Q38662366-72209CBF-F053-45D2-B265-300305F19A76Q49243354-45F9D4EB-BCAB-43C6-A230-F0EF8F0D979FQ53691928-2A9CDA59-F002-4FA5-80D7-5B5C74A01CE2
P2860
Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Tuberculosis risk factors and ...... viral therapy in South Africa.
@ast
Tuberculosis risk factors and ...... viral therapy in South Africa.
@en
type
label
Tuberculosis risk factors and ...... viral therapy in South Africa.
@ast
Tuberculosis risk factors and ...... viral therapy in South Africa.
@en
prefLabel
Tuberculosis risk factors and ...... viral therapy in South Africa.
@ast
Tuberculosis risk factors and ...... viral therapy in South Africa.
@en
P2093
P2860
P921
P1433
P1476
Tuberculosis risk factors and ...... viral therapy in South Africa.
@en
P2093
Henry Masur
Julia A Metcalf
Lizette Malan
Monkwe J Mathibedi
Nomso Stubbs
Pamela A Shaw
Phumelele Sangweni
Shaheen Hassim
Stephanus Komati
P2860
P304
P356
10.1097/QAD.0B013E32833A2507
P407
P577
2010-07-01T00:00:00Z